Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Sudden death after 125I brachytherapy in prostate cancer patient: a case report].
Kimura M, Satoh T, Fujita T, Okusa H, Matsumoto K, Iwamura M, Kitano M, Ishiyama H, Hayakawa K, Okayasu I, Baba S. Kimura M, et al. Among authors: matsumoto k. Nihon Hinyokika Gakkai Zasshi. 2005 Jul;96(5):560-3. doi: 10.5980/jpnjurol1989.96.560. Nihon Hinyokika Gakkai Zasshi. 2005. PMID: 16083034 Free article. Japanese.
Ammonium acid urate urolithiasis in Japan.
Kuruma H, Arakawa T, Kubo S, Hyodo T, Matsumoto K, Satoh T, Egawa S, Baba S. Kuruma H, et al. Among authors: matsumoto k. Int J Urol. 2006 May;13(5):498-501. doi: 10.1111/j.1442-2042.2006.01348.x. Int J Urol. 2006. PMID: 16771715
[8-month neoadjuvant hormonal therapy before radical prostatectomy for high-risk prostate cancer].
Tabata K, Satoh T, Matsumoto K, Fujita T, Irie A, Iwamura M, Yanagisawa N, Matsuda D, Muramoto M, Kadowaki K, Suyama K, Shoji K, Koh H, Kawakami T, Okayasu I, Egawa S, Baba S. Tabata K, et al. Among authors: matsumoto k. Nihon Hinyokika Gakkai Zasshi. 2006 Jul;97(5):712-8. doi: 10.5980/jpnjurol1989.97.712. Nihon Hinyokika Gakkai Zasshi. 2006. PMID: 16898594 Free article. Clinical Trial. Japanese.
Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
Satoh T, Ishiyama H, Matsumoto K, Tsumura H, Kitano M, Hayakawa K, Ebara S, Nasu Y, Kumon H, Kanazawa S, Miki K, Egawa S, Aoki M, Toya K, Yorozu A, Nagata H, Saito S, Baba S. Satoh T, et al. Among authors: matsumoto k. BJU Int. 2009 Apr;103(8):1064-8. doi: 10.1111/j.1464-410X.2008.08234.x. Epub 2008 Nov 25. BJU Int. 2009. PMID: 19040526
Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.
Ishiyama H, Kitano M, Satoh T, Kotani S, Uemae M, Matsumoto K, Okusa H, Tabata K, Baba S, Hayakawa K. Ishiyama H, et al. Among authors: matsumoto k. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):23-8. doi: 10.1016/j.ijrobp.2008.11.006. Epub 2009 Feb 23. Int J Radiat Oncol Biol Phys. 2009. PMID: 19243900
[Tick-bite in penile skin : a case report].
Nishi M, Matsumoto K, Sawamura M, Nakamura K, Hayashi T, Satoh T, Iwamura M, Baba S. Nishi M, et al. Among authors: matsumoto k. Hinyokika Kiyo. 2010 Mar;56(3):185-7. Hinyokika Kiyo. 2010. PMID: 20372050 Free article. Japanese.
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF. Matsumoto K, et al. BJU Int. 2011 Oct;108(8 Pt 2):E304-9. doi: 10.1111/j.1464-410X.2011.10188.x. Epub 2011 Apr 20. BJU Int. 2011. PMID: 21507184 Free article.
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
Tsumura H, Satoh T, Ishiyama H, Tabata K, Kotani S, Minamida S, Kimura M, Fujita T, Matsumoto K, Kitano M, Hayakawa K, Baba S. Tsumura H, et al. Among authors: matsumoto k. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e385-92. doi: 10.1016/j.ijrobp.2011.04.026. Epub 2011 Jun 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 21664068 Clinical Trial.
Immunohistochemical biomarkers for bladder cancer prognosis.
Matsushita K, Cha EK, Matsumoto K, Baba S, Chromecki TF, Fajkovic H, Sun M, Karakiewicz PI, Scherr DS, Shariat SF. Matsushita K, et al. Among authors: matsumoto k. Int J Urol. 2011 Sep;18(9):616-29. doi: 10.1111/j.1442-2042.2011.02809.x. Epub 2011 Jul 20. Int J Urol. 2011. PMID: 21771101
The radiotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin treatment is an effective therapeutic option in patients with advanced or metastatic bladder cancer.
Ikeda M, Matsumoto K, Niibe Y, Satoh T, Fujita T, Iwamura M, Ishiyama H, Kotani S, Hayakawa K, Baba S. Ikeda M, et al. Among authors: matsumoto k. J Radiat Res. 2011;52(5):674-9. doi: 10.1269/jrr.11036. Epub 2011 Sep 1. J Radiat Res. 2011. PMID: 21881297 Free article. Clinical Trial.
EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy.
Kurosaka S, Satoh T, Chow E, Asano Y, Tabata K, Kimura M, Tsumura H, Matsumoto K, Ishiyama H, Inoue Y, Hayakawa K, Baba S. Kurosaka S, et al. Among authors: matsumoto k. Ann Nucl Med. 2012 Jul;26(6):485-91. doi: 10.1007/s12149-012-0598-z. Epub 2012 Apr 3. Ann Nucl Med. 2012. PMID: 22477263 Clinical Trial.
10,301 results
You have reached the last available page of results. Please see the User Guide for more information.